The Hippo effector YAP regulates the response of cancer cells to MAPK pathway inhibitors

被引：28

作者：

Lin, Luping ^{[1
,2
]}

Bivona, Trever G. ^{[1
,2
]}

机构：

[1] Univ Calif San Francisco, Div Hematol & Med Oncol, San Francisco, CA 94143 USA

[2] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA

来源：

MOLECULAR & CELLULAR ONCOLOGY | 2016年 / 3卷 / 01期

关键词：

BRAF; Hippo; MEK; resistance; RAS; targeted therapy; YAP;

D O I：

10.1080/23723556.2015.1021441

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

RAF- and MEK-targeted therapies are approved for patients with BRAFV600E melanoma and under investigation in a several other tumor types, but resistance remains a major challenge. We uncovered yes-associated protein 1 (YAP1) as a mechanism of resistance to RAF-MEK inhibition in BRAF- and RAS-mutant cancers, providing a rationale for co-targeting YAP and RAF-MEK to enhance patient outcomes.

引用

页数：2

共 50 条

[41] The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Cunningham, Richard
Hansen, Carsten Gram
CLINICAL SCIENCE, 2022, 136 (03) : 197 - 222
[42] The Hippo superhighway: signaling crossroads converging on the Hippo/Yap pathway in stem cells and development
Barry, Evan R.
Camargo, Fernando D.
CURRENT OPINION IN CELL BIOLOGY, 2013, 25 (02) : 247 - 253
[43] A YAP/TAZ-induced feedback mechanism regulates Hippo pathway homeostasis
Moroishi, Toshiro
Park, Hyun Woo
Qin, Baodong
Chen, Qian
Meng, Zhipeng
Plouffe, Steven W.
Taniguchi, Koji
Yu, Fa-Xing
Karin, Michael
Pan, Duojia
Guan, Kun-Liang
GENES & DEVELOPMENT, 2015, 29 (12) : 1271 - 1284
[44] Clinical potential of the Hippo-YAP pathway in bladder cancer
Cheng, Xin
Lou, Kecheng
Ding, Liang
Zou, Xiaofeng
Huang, Ruohui
Xu, Gang
Zou, Junrong
Zhang, Guoxi
FRONTIERS IN ONCOLOGY, 2022, 12
[45] YAP/Hippo Pathway and Cancer Immunity: It Takes Two to Tango
Matthaios, Dimitrios
Tolia, Maria
Mauri, Davide
Kamposioras, Konstantinos
Karamouzis, Michalis
BIOMEDICINES, 2021, 9 (12)
[46] properties through the Hippo-YAP pathway in prostate cancer
Jiang, Donggen
Li, Jun
Ma, He
Yan, Binyuan
Lei, Hanqi
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES, 2025, 22 (02): : 460 - 472
[47] The role of the Hippo/YAP pathway in cancer drug resistance.
Bivona, Trever
MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 17 - 17
[48] Activation of the Hippo/YAP signaling pathway in gastric epithelial cells in response to Helicobacter pylori infection
Molina-Castro, S.
Staedel, C.
Fernandez, S.
Giraud, J.
Bessede, E.
Lehours, P.
Megraud, F.
Varon, C.
HELICOBACTER, 2016, 21 : 86 - 87
[49] Maintenance of retinal stem cells: the role of YAP, a downstream effector of the Hippo pathway, in DNA replication timing and genomic stability
Perron, Muriel
Cabochette, Pauline
Vega-Lopez, Guillermo
Bitard, Juliette
Parain, Karine
Masson, Christel
Hedderich, Marie
Henningfeld, Kristine
Locker, Morgane
Bronchain, Odile
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
[50] The Hippo pathway effector YAP inhibits HIF2 signaling and ccRCC tumor growth
Xu Li
Yong Suk Cho
Jian Zhu
Shu Zhuo
Jin Jiang
Cell Discovery, 8

← 1 2 3 4 5 →